Ingredion Incorporated (INGR)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NYSE
Market Cap: $5.86B
Last updated: Nov 17, 2026 at 11:05 AM ET
Ingredion Incorporated (INGR) Stock Forecast
Analysts expect Ingredion (INGR) to earn $9.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $7.15B. Of 7 analysts, 2 rate the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.57, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 29% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 1 | 14.3% |
| Hold | 5 | 71.4% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.0% and revenue estimates rise 1.8%.
- Fiscal year ending Dec 31, 2026
- $9.55
- EPS consensus, revenue $7.15B
- Fiscal year ending Dec 31, 2027
- $10.31
- EPS consensus, revenue $7.28B
- Next report
- Feb 1, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $9.55 | $9.27 to $10.16 | 7 | $7.15B | $7.14B to $7.18B | 6 |
| Dec 31, 2027 | $10.31 | $10.00 to $10.80 | 7 | $7.28B | $7.16B to $7.38B | 6 |
Quarterly Estimates
The EPS consensus rises from $2.04 for the quarter ending Dec 31, 2026 to $2.24 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.04 | $1.77 to $2.20 | 9 | $1.76B | $1.68B to $1.83B | 8 |
| Mar 31, 2027 | $2.24 | $2.17 to $2.38 | 3 | $1.79B | $1.75B to $1.84B | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 9 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 3 |
| Fiscal year ending Dec 31, 2027 | 0 | 3 |
| Quarter ending Mar 31, 2027 | 0 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 9.6% from $10.57.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $9.55 | $10.46 | $10.51 | $10.57 | $10.57 | -9.6% |
| Fiscal year ending Dec 31, 2027 | $10.31 | $11.23 | $11.26 | $11.35 | $11.35 | -9.2% |
| Quarter ending Mar 31, 2027 | $2.24 | $2.72 | $2.72 | $2.73 | $2.73 | -17.7% |
Frequently Asked Questions About INGR
What is the INGR stock forecast?
Consensus analyst estimates put Ingredion's EPS at $9.55 for the fiscal year ending Dec 31, 2026, on revenue of $7.15B. The consensus rating from 7 analysts is Hold.
How do analysts rate INGR stock?
Of 7 analysts covering Ingredion, 1 rates it Strong Buy, 1 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from INGR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $9.55, with estimates from $9.27 to $10.16 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $10.31, with estimates from $10.00 to $10.80 from 7 analysts.
What revenue do analysts expect from Ingredion next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $7.15B, with estimates from $7.14B to $7.18B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $7.28B, with estimates from $7.16B to $7.38B.
How many analysts cover INGR?
7 analysts rate Ingredion stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
INGR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors